The Enterprise Value as of November 2024 (TTM) for Cytek Biosciences, Inc. (CTKB) is 690.43M

According to Cytek Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 690.43M. This represents a change of -6.31% compared to the average of 736.94M of the last 4 quarters.

Cytek Biosciences, Inc. (CTKB) Historical Enterprise Value (quarterly & annually)

How has CTKB Enterprise Value performed in the past?

The mean historical Enterprise Value of Cytek Biosciences, Inc. over the last ten years is 1.76B. The current 690.43M Enterprise Value has changed 3.83% with respect to the historical average. Over the past ten years (40 quarters), CTKB's Enterprise Value was at its highest in in the June 2021 quarter at 2.29B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Cytek Biosciences, Inc. (CTKB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cytek Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cytek Biosciences, Inc. (CTKB) Average Enterprise Value

How has CTKB Enterprise Value performed in the past?

The current Enterprise Value of Cytek Biosciences, Inc. (CTKB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cytek Biosciences, Inc. (CTKB) Enterprise Value vs. Peers

How is CTKB’s Enterprise Value compared to its peers?

Cytek Biosciences, Inc.’s Enterprise Value is less than Heska Corporation (1.26B), greater than OrthoPediatrics Corp. (611.40M), greater than Electromed, Inc. (238.10M), greater than Pulmonx Corporation (260.62M), less than RxSight, Inc. (1.80B), greater than AxoGen, Inc. (637.27M), greater than Treace Medical Concepts, Inc. (545.80M), less than Orthofix Medical Inc. (829.81M), greater than NeuroPace, Inc. (347.61M), greater than Inogen, Inc. (137.87M), greater than Surmodics, Inc. (554.56M), greater than Apyx Medical Corporation (65.23M), greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (3.12B), greater than Sight Sciences, Inc. (120.25M), greater than STRATA Skin Sciences, Inc. (22.14M), greater than Vapotherm, Inc. (133.30M), greater than Talis Biomedical Corporation (-37986434.00),

Build a custom stock screener for Cytek Biosciences, Inc. (CTKB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytek Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cytek Biosciences, Inc. (CTKB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cytek Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.